Free shipping on all orders over $ 500

GRA Ex-25

Cat. No. M8940

All AbMole products are for research use only, cannot be used for human consumption.

GRA Ex-25 Structure
Size Price Availability Quantity
5mg USD 185 In stock
10mg USD 260 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GRA Ex-25 is an inhibitor of glucagon receptor. GRA Ex-25 binds a human glucagon receptor (h-GlucRbind) with Ki of 63 nM and a moderate glucagon induced adenylate cyclase inhibition (h-GlucRcyclase) with Ki of 254 nM under our assay conditions.

In vivo: GRA Ex-25 (3 mg/kg, i.v.) significantly reduces blood glucose caused by exogenous administration of glucagon in rat model. GRA Ex-25 is able to inhibit the rise in blood glucose levels elicited by exogenous administered glucagon, most likely because of the direct inhibition of glucagon stimulated hepatic glucose output.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Non-fasted male Sprague Dawley rats (200 g)
Formulation
Dosages 0, 1, 3, 10 and 30 mg/kg
Administration acatheter inserted in a jugular vein
Chemical Information
Molecular Weight 563.61
Formula C29H36F3N3O5
CAS Number 307983-31-9
Solubility (25°C) DMSO: ≥ 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Guan HP, et al. J Lipid Res. Glucagon receptor antagonism induces increased cholesterol absorption.

Related Glucagon Receptor Products
PF-06291874

PF-06291874 is an orally active, potent and selective glucagon receptor antagonist.

Glucagon (1-29), bovine, human, porcine

Glucagon (1-29), bovine, human, porcine is a peptide hormone, produced by pancreatic α-cells. Glucagon stimulates gluconeogenesis. Glucagon (1-29), bovine, human, porcine activates HNF4α and increases HNF4α phosphorylation.

NNC0640

NNC0640 is a potent, negative allosteric modulator (NAM) of human G-protein-coupled glucagon receptor (GCGR) with IC50 of 69.2 nM.

Dasiglucagon acetate

Dasiglucagon acetate is a Glucagon Receptor Agonist. The physiologic effect of dasiglucagon is by means of Increased Glycogenolysis.

Adomeglivant

Adomeglivant (LY2409021) is a potent, selective glucagon receptor (GluR) allosteric antagonist. Adomeglivant is widely used in the research for type 2 diabetes mellitus.

  Catalog
Abmole Inhibitor Catalog




Keywords: GRA Ex-25 supplier, Glucagon Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.